Boule Diagnostics AB (publ) (STO:BOUL)
Sweden · Delayed Price · Currency is SEK 3.650
+0.140 (3.99%)
Jul 24, 2026, 5:29 PM CET
Boule Diagnostics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 461.29 | 489.69 | 558.46 | 571.33 | 548.09 | 463.34 | |
Revenue Growth (YoY) | -10.58% | -12.31% | -2.25% | 4.24% | 18.29% | 15.70% |
Cost of Revenue | 262.98 | 275.88 | 306.23 | 321.62 | 320.18 | 264.71 |
Gross Profit | 198.31 | 213.81 | 252.23 | 249.71 | 227.91 | 198.63 |
Selling, General & Admin | 124.44 | 129.64 | 162.39 | 153.35 | 143.6 | 120.15 |
Research & Development | 52.87 | 58.87 | 399.45 | 53.09 | 51.57 | 43.33 |
Other Operating Expenses | 2.69 | 4.49 | 40.09 | 4 | 3.77 | -0.86 |
Total Operating Expenses | 179.99 | 192.99 | 601.93 | 210.44 | 198.93 | 162.62 |
Operating Income | 18.32 | 20.82 | -349.7 | 39.27 | 28.97 | 36.02 |
Interest Income | 0.62 | 1.52 | 1.39 | 2.17 | 1.78 | 1.35 |
Interest Expense | -16.88 | -16.28 | -12.59 | -11.3 | -9.9 | -5.49 |
Other Non-Operating Income (Expense) | - | -0.15 | 0.15 | -0.03 | 0.01 | -3.11 |
Total Non-Operating Income (Expense) | -16.26 | -14.91 | -11.06 | -9.17 | -8.12 | -7.25 |
Pretax Income | 1.81 | 5.91 | -360.75 | 30.1 | 20.85 | 28.77 |
Provision for Income Taxes | 5.76 | 9.66 | -64.17 | 5.12 | 8.12 | 5.5 |
Net Income | -3.95 | -3.75 | -296.58 | 24.98 | 12.73 | 23.27 |
Net Income to Common | -3.75 | -3.75 | -296.58 | 24.98 | 12.73 | 23.27 |
Net Income Growth | - | - | - | 96.24% | -45.31% | - |
Shares Outstanding (Basic) | 16 | 39 | 39 | 39 | 28 | 27 |
Shares Outstanding (Diluted) | 16 | 39 | 39 | 39 | 28 | 27 |
Shares Change (YoY) | -98.94% | - | - | 36.37% | 4.65% | 36.29% |
EPS (Basic) | -0.23 | -0.10 | -7.64 | 0.64 | 0.46 | 0.87 |
EPS (Diluted) | -0.23 | -0.10 | -7.64 | 0.64 | 0.45 | 0.86 |
EPS Growth | - | - | - | 42.22% | -47.67% | - |
Free Cash Flow | 18.44 | -2.66 | 37.68 | 44.51 | -17.79 | 40.14 |
Free Cash Flow Growth | 430.52% | - | -15.35% | - | - | -43.20% |
Free Cash Flow Per Share | 1.13 | -0.07 | 0.97 | 1.15 | -0.62 | 1.47 |
Dividends Per Share | - | - | - | - | - | 0.550 |
Dividend Growth | - | - | - | - | - | 0% |
Gross Margin | 42.99% | 43.66% | 45.16% | 43.71% | 41.58% | 42.87% |
Operating Margin | 3.97% | 4.25% | -62.62% | 6.87% | 5.29% | 7.77% |
Profit Margin | -0.86% | -0.77% | -53.11% | 4.37% | 2.32% | 5.02% |
FCF Margin | 4.00% | -0.54% | 6.75% | 7.79% | -3.25% | 8.66% |
EBITDA | 18.32 | 39.42 | -326.76 | 63.89 | 28.97 | 36.02 |
EBITDA Margin | 3.97% | 8.05% | -58.51% | 11.18% | 5.29% | 7.77% |
EBIT | 18.32 | 20.82 | -349.7 | 39.27 | 28.97 | 36.02 |
EBIT Margin | 3.97% | 4.25% | -62.62% | 6.87% | 5.29% | 7.77% |
Effective Tax Rate | 318.28% | 163.49% | 17.79% | 17.02% | 38.95% | 19.10% |